Bora Pharmaceuticals looks to enter the cell and gene therapy CDMO space 09-Dec-2021 By Jane Byrne Taiwan based contract manufacturer, Bora Pharmaceuticals, in partnership with Taishin Healthcare Limited, is ready to spend millions to expand its footprint in the CDMO sector.
Proposed Herceptin biosimilar to be marketed by Sandoz 02-May-2019 By Maggie Lynch Sandoz inks agreement with EirGenix to commercialize a Herceptin biosimilar currently in late-stage development.